People · Operator
Named in public records as an officer, director or promoter · active 2020–2024 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Brain Corp | — | Other Technology | Series B | $68.3M | $272.3M | 2020 |
| Renova Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $167K | $740K | 2024 |
Shawn Swaney at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Shawn Swaney on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Scott Carter | 1 | 6 |
| Michael Torres | 1 | 5 |
| Kevin Turner | 1 | 4 |
| Harvey White | 1 | 3 |
| William Davidson | 1 | 2 |
| Steve Altman | 1 | 2 |
| Roy Cosan | 1 | 2 |
| Morgan Xu | 1 | 1 |
| Richard Tapalaga | 1 | 1 |
| Eugene Izhikevich | 1 | 1 |
| Andy Ng | 1 | 1 |
| Pierre Lecocq | 1 | 1 |
| Scott Henry | 1 | 1 |
| Brian Reinhart | 1 | 1 |
| Jarad Cannon | 1 | 1 |
| David Pinn | 1 | 1 |
| Chris Lobdell | 1 | 1 |
| Anthony Hucker | 1 | 1 |
| Allen Gruber | 1 | 1 |
| Fay West | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.